Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022
Publication
, Conference
Yu, J; Mohammed, TJ; Chin-Yee, B; Skorupski, C; Gyawali, B; Lyman, GH; Adkins, L; Hicks, LK; Kuderer, NM
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yu, J., Mohammed, T. J., Chin-Yee, B., Skorupski, C., Gyawali, B., Lyman, G. H., … Kuderer, N. M. (2023). Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Yu, James, Turab J. Mohammed, Benjamin Chin-Yee, Clarissa Skorupski, Bishal Gyawali, Gary H. Lyman, Lauren Adkins, Lisa K. Hicks, and Nicole M. Kuderer. “Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Yu J, Mohammed TJ, Chin-Yee B, Skorupski C, Gyawali B, Lyman GH, et al. Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Yu, James, et al. “Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Yu J, Mohammed TJ, Chin-Yee B, Skorupski C, Gyawali B, Lyman GH, Adkins L, Hicks LK, Kuderer NM. Toxicity reporting consistency and subjective minimizing language use in colorectal cancer (CRC) and pancreatic cancer (PaC) clinical trials: A systematic review of phase III randomized controlled trials (RCTs) presented at ASCO between 2012-2022. JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences